arrow
H

Heung Tae Kim

immuneoncia therapeutics inc.
H指数:33
被引数:5,273

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Danburstotug, an anti-PD-L1 antibody, in relapsed/refractory extra-nodal natural killer/T-cell lymphoma: The phase 2 DISTINKT study

丹努斯妥昔单抗(Danburstotug),一种抗PD-L1抗体,在复发/难治性结外自然杀伤/T细胞淋巴瘤中的应用:DISTINKT二期研究

2026-09-050
PRE
ASSOCIATION OF T-CELL-INFLAMED GENE EXPRESSION PROFILE AND PD-L1 STATUS WITH EFFICACY OF PEMBROLIZUMAB IN PATIENTS WITH ESOPHAGEAL CANCER FROM KEYNOTE-180
2020-11-091
PREAI
Clinical Outcome According to the Level of Preexisting Epidermal Growth Factor Receptor T790M Mutation in Patients With Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations

根据先前存在的表皮生长因子受体T790M突变水平评估具有敏感表皮生长因子受体突变的肺癌患者的临床结局

CANCER
IF5.1
2014-04-1562
OAAI